Braveheart Investment Group plc
13 July 2007
13 July 2007
Braveheart Investment Group plc
('Braveheart' or the 'Group')
Award of Options
Braveheart (AIM: BRH), the technology commercialisation and investment
management company, announces that, as part of its long term investment plan
detailed in its Admission Document, the directors and staff named below have
been awarded the following options over the Group's Ordinary Shares:
Employment Performance Total
based based
Directors
Garry Watson - 100,361 100,361
Edward Cunningham - 40,079 40,079
Donald Turner - 40,079 40,079
Geoffrey Thomson 24,948 253,010 277,958
Carolyn Smith 18,480 151,806 170,286
Total 43,428 585,335 628,763
Staff
Total 37,883 177,108 214,991
Grand Total 81,311 762,443 843,754
For further information, please contact:
Braveheart Investment Group Tavistock Communications
Geoffrey Thomson Rachel Drysdale
Chief Executive Simon Hudson
Tel: 01738 587555 Tel: 020 7920 3150
rdrysdale@tavistock.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
RD
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.